Hartmann G - Search Results

1

Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence.

Gross O, Poeck H, Bscheider M, Dostert C, Hannesschläger N, Endres S, Hartmann G, Tardivel A, Schweighoffer E, Tybulewicz V, Mocsai A, Tschopp J, Ruland J. Gross O, et al. Among authors: hartmann g. Nature. 2009 May 21;459(7245):433-6. doi: 10.1038/nature07965. Epub 2009 Apr 1. Nature. 2009. PMID: 19339971

2

CpG oligonucleotides: novel regulators of osteoclast differentiation.

Zou W, Schwartz H, Endres S, Hartmann G, Bar-Shavit Z. Zou W, et al. Among authors: hartmann g. FASEB J. 2002 Mar;16(3):274-82. doi: 10.1096/fj.01-0586com. FASEB J. 2002. PMID: 11874977

3

Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides.

Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdörfer B, Giese T, Endres S, Hartmann G. Hornung V, et al. Among authors: hartmann g. J Immunol. 2002 May 1;168(9):4531-7. doi: 10.4049/jimmunol.168.9.4531. J Immunol. 2002. PMID: 11970999

4

Peritumoral CpG DNA elicits a coordinated response of CD8 T cells and innate effectors to cure established tumors in a murine colon carcinoma model.

Heckelsmiller K, Rall K, Beck S, Schlamp A, Seiderer J, Jahrsdörfer B, Krug A, Rothenfusser S, Endres S, Hartmann G. Heckelsmiller K, et al. Among authors: hartmann g. J Immunol. 2002 Oct 1;169(7):3892-9. doi: 10.4049/jimmunol.169.7.3892. J Immunol. 2002. PMID: 12244187

5

Plasmacytoid dendritic cells: the key to CpG.

Rothenfusser S, Tuma E, Endres S, Hartmann G. Rothenfusser S, et al. Among authors: hartmann g. Hum Immunol. 2002 Dec;63(12):1111-9. doi: 10.1016/s0198-8859(02)00749-8. Hum Immunol. 2002. PMID: 12480254 Review.

6

Combined dendritic cell- and CpG oligonucleotide-based immune therapy cures large murine tumors that resist chemotherapy.

Heckelsmiller K, Beck S, Rall K, Sipos B, Schlamp A, Tuma E, Rothenfusser S, Endres S, Hartmann G. Heckelsmiller K, et al. Among authors: hartmann g. Eur J Immunol. 2002 Nov;32(11):3235-45. doi: 10.1002/1521-4141(200211)32:11<3235::AID-IMMU3235>3.0.CO;2-J. Eur J Immunol. 2002. PMID: 12555669 Free article.

7

CpG-A oligonucleotides induce a monocyte-derived dendritic cell-like phenotype that preferentially activates CD8 T cells.

Krug A, Rothenfusser S, Selinger S, Bock C, Kerkmann M, Battiany J, Sarris A, Giese T, Speiser D, Endres S, Hartmann G. Krug A, et al. Among authors: hartmann g. J Immunol. 2003 Apr 1;170(7):3468-77. doi: 10.4049/jimmunol.170.7.3468. J Immunol. 2003. PMID: 12646607

8

Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells.

Kerkmann M, Rothenfusser S, Hornung V, Towarowski A, Wagner M, Sarris A, Giese T, Endres S, Hartmann G. Kerkmann M, et al. Among authors: hartmann g. J Immunol. 2003 May 1;170(9):4465-74. doi: 10.4049/jimmunol.170.9.4465. J Immunol. 2003. PMID: 12707322

9

Recent advances in immunostimulatory CpG oligonucleotides.

Rothenfusser S, Tuma E, Wagner M, Endres S, Hartmann G. Rothenfusser S, et al. Among authors: hartmann g. Curr Opin Mol Ther. 2003 Apr;5(2):98-106. Curr Opin Mol Ther. 2003. PMID: 12772497 Review.

10

Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells.

Hartmann G, Battiany J, Poeck H, Wagner M, Kerkmann M, Lubenow N, Rothenfusser S, Endres S. Hartmann G, et al. Eur J Immunol. 2003 Jun;33(6):1633-41. doi: 10.1002/eji.200323813. Eur J Immunol. 2003. PMID: 12778481 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

804 results

Search Page

Filters